Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management platform, underpinned by digital technologies. The Tempo system brings ...

Meanwhile, Lilly also confirmed that it will start running a head-to-head cardiovascular outcomes trial for Trulicity and one of its pipeline diabetes candidates – dual GIP/GLP1 agonist ...

Aside from their success for type 2 diabetes and overweight/obesity ... In the study – which was sponsored by drugmaker Eli Lilly – over 800 participants underwent 12 weeks of intensive lifestyle ...

NVO's fourth-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, especially Wegovy, Ozempic and Rybelsus. Here's why they view Eli Lilly (NYSE ...

Eli Lilly and Company discovers ... and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It provides oncology products, including ...

Those at risk include people living with type 2 diabetes or high blood pr Eli Lilly and Company (NYSE: LLY) today announced a $3 billion expansion of the Kenosha County, Wisconsin, manufacturing ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more The best sheets make your bed a cozy, dreamy oasis — they're comfortable, well-fitting and don't ...

With so many bedding start-ups promising premium-quality sheets for less, it can be hard to keep everything straight, especially now that it feels like every home company is getting in the bedding ...